To address this issue, I analyzed the contents of the 2000 Annual Meeting New Research Program and Abstracts(2), with a focus on medications versus nonmedications (including ECT, light therapy, and transcranial magnetic stimulation). There were originally 739 abstracts, but two presentations were withdrawn. Therefore, 737 abstracts were analyzed (214 in the "Young Investigators" category). In my content analysis, 313 presentations focused on various medications, and 424 focused on other aspects of psychiatric research. Statistical analysis revealed interesting trends: 231 abstracts written by U.S. presenters (based on the first author’s affiliation) focused on medications and 270 on other aspects of psychiatry; 82 abstracts written by international presenters focused on medications and 154 on other aspects of psychiatry (χ2=8.48, df=1, p=0.04). There was a significant difference between those not in the Young Investigators category (senior investigators): 190 medication-focused abstracts versus 173 nonmedication-focused abstracts among U.S. presenters and 62 versus 98 abstracts, respectively, among international presenters (χ2=8.22, df=1, p=0.04). The difference among Young Investigators was not significant (41 medication-focused abstracts versus 97 nonmedication-focused abstracts among U.S. presenters and 20 versus 56 among international presenters; χ2=0.28, df=1, n.s.). The difference between all Young Investigators (medication-focused: 61, nonmedication-focused: 153) and all senior investigators (252 and 271, respectively) was significant (χ2=24.07, df=1, p<0.001). This difference was accounted for mostly by the difference between young and senior U.S. presenters (χ2=20.61, df=1, p<0.001) because the difference between young and senior international presenters (χ2=3.52, df=1, p=0.06) was marginal.